The Blackmores Limited (ASX: BKL) share price was trading 5.70% higher today. Over the past month, shares of Blackmores Limited are down 6%. For comparison, the S&P/ASX 200 (INDEXASX: XJO) has climbed 1% at the same time.
About Blackmores Limited
Blackmores describes itself as Australia’s leading natural health company. Maurice Blackmore founded the company in the 1930s.
Blackmores has a number of different brands, not just the well-recognised Blackmores brand. It operates BioCeuticals, the Blackmores Institute, Fusion Health & Oriental Botanicals, Impromy, IsoWhey and Pure Animal Wellbeing (PAW).
What’s Happened?
Overnight, the US and China trade war appeared to have provided investors with some positive news (finally!). As Rask Media’s Jaz Harrison reported:
“US President Trump has announced that the United States will delay its tariff increases on Chinese goods by two weeks as a gesture of goodwill.”
Adding, “These delays came as China decided to release a list of 16 US imports that will be exempted from tariffs such as animal feed and anti-cancer medication.”
For companies — and ASX investors — who have something to lose if it’s harder to trade internationally, this is very welcome news. Heck, even if it is just a “gesture”!
Indeed, this news is probably the reason why shares of companies like Blackmores, a2 Milk Company Ltd (ASX: A2M) and even the likes of BHP Group Ltd (ASX: BHP) are trading higher today.
Buy, Hold or Sell?
I wouldn’t bet the house (or my investment dollars) on a trade resolution anytime soon.
However, I would and do make investments based on the long-term growth prospects of high-quality businesses like A2 Milk and Blackmores.
For that reason, I’ll be taking a closer look at shares of both companies in the coming months. Both companies have a foothold in China with established marketing and distribution teams. That’s more than can be said of many Australian-only focused mid-cap companies.
Having said that, we’ve identified proven ASX growth + dividend companies in our new investing report below.
[ls_content_block id=”14945″ para=”paragraphs”]
Disclosure: At the time of publishing, Owen does not have a financial interest in any of the companies mentioned.